Targeted cancer therapy--are the days of systemic chemotherapy numbered? - Wikidata - awgldk - TriplyDB

Targeted cancer therapy--are the days of systemic chemotherapy numbered?

Targeted cancer therapy--are the days of systemic chemotherapy numbered?

http://www.wikidata.org/entity/Q36174805

about

Recent developments in receptor tyrosine kinases targeted anticancer therapy Cancer Metabolism and Drug Resistance Applications of calixarenes in cancer chemotherapy: facts and perspectives Fucoidan and cancer: a multifunctional molecule with anti-tumor potential Stem cells' guided gene therapy of cancer: New frontier in personalized and targeted therapy.Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.Formulation development of a novel targeted theranostic nanoemulsion of docetaxel to overcome multidrug resistance in ovarian cancer.Human Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer.Oligonucleotide-based theranostic nanoparticles in cancer therapy.Biomaterials for Abrogating Metastasis: Bridging the Gap between Basic and Translational Research.

P2860

Q26751331-7980711A-D11E-400F-9C4C-FC24FD2F5073 Q26782042-1EA07E84-9E80-4654-AD8E-59CA75B64D4F Q26995815-CF0F37A8-C39D-4B1A-87FB-BB6E97C11787 Q27021858-86368E93-F167-4DD2-8574-EFA21BD2C760 Q33653485-2319EF39-76F4-4CAD-8092-794309E6006D Q34103963-C722C401-8D5B-4474-B59E-10D0EB7FAD7D Q35236565-AE10AB1E-ABF4-4528-8128-91D55C3A2A91 Q36563742-25253BD5-C33A-4D47-ABBC-7C839A891C4A Q38814327-477978D9-0380-4D67-9456-3FA3D8C8164F Q51231785-A739E804-09A2-4E5D-888A-3E2F008D2FC4

P2860

Targeted cancer therapy--are the days of systemic chemotherapy numbered?

http://www.wikidata.org/entity/Q36174805

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Targeted cancer therapy--are the days of systemic chemotherapy numbered?

@ast

Targeted cancer therapy--are the days of systemic chemotherapy numbered?

@en

type

label

Targeted cancer therapy--are the days of systemic chemotherapy numbered?

@ast

Targeted cancer therapy--are the days of systemic chemotherapy numbered?

@en

prefLabel

Targeted cancer therapy--are the days of systemic chemotherapy numbered?

@ast

Targeted cancer therapy--are the days of systemic chemotherapy numbered?

@en

P1433

Q36174805-DE0F24C5-CEAC-47AF-A948-01B15B1C9A45

P1476

Q36174805-C07A613F-C41E-4F3F-9E32-3A35A81BEAC7

P2093

Q36174805-35EA2F12-69ED-4598-AF63-7FD16D61252B

Q36174805-811E0E7E-5DA8-4D4B-85BD-B8C55C11E04B

Q36174805-8D606152-B04F-416B-9F1D-8549B79063F9

P2860

Q36174805-0736181C-71A5-4ADA-8A42-35C222B90C31

Q36174805-0AC8E697-A56E-46F3-8336-46F10A4E7F01

Q36174805-0FA7C35A-F861-45CC-A1F4-925DC0D25142

Q36174805-179598B9-61B4-4255-9130-2DD5919A1369

Q36174805-1926D117-53D4-42B5-BE22-AE36A6014C53

Q36174805-2E8A5A21-0DD6-45C0-8AF3-7E6B06236360

Q36174805-30352EF5-D17D-4695-BAAF-2B88C86AF659

Q36174805-328D600D-AF74-4C4C-85DF-0AAA2152E180

Q36174805-32C37B0E-1688-4B74-8347-E1ABC17298FC

Q36174805-34185584-E594-4ACD-BF25-B1841B879032

P304

Q36174805-75776971-D56B-4E6D-9DC2-C9FD4C09D288

P31

Q36174805-25C60215-A05F-47DE-B6AB-EA367ADD9944

P356

Q36174805-1F4E41C1-A55A-466D-8A0B-94BF23E0F9F8

P433

Q36174805-74947C1D-DC89-423E-AAF5-EE0650A16BE3

P478

Q36174805-AE080488-7A11-4146-A4F8-D2150A024EB0

P577

Q36174805-C2411497-8081-4A7D-873C-7C2FA14AC803

P5875

Q36174805-9F1AAD43-39D1-4285-B1D0-798EFDA40CE5

P698

Q36174805-927A14B8-8AE5-40D9-8C7D-A8C56670B6E5

P921

Q36174805-B06F7F50-9FE5-4C39-A58F-B8D8AC3DE3D5

P932

Q36174805-774FC242-1088-49DA-A5DC-CE5A96147CD4

P356

J.MATURITAS.2013.09.008

P1433

P1476

Targeted cancer therapy--are the days of systemic chemotherapy numbered?

@en

P2093

Gil Mor

http://www.w3.org/2001/XMLSchema#string

Irene Visintin

http://www.w3.org/2001/XMLSchema#string

Won Duk Joo

http://www.w3.org/2001/XMLSchema#string

P2860

Salinomycin as a drug for targeting human cancer stem cells

Identification and characterization of ovarian cancer-initiating cells from primary human tumors

Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer

Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.

Trastuzumab emtansine for HER2-positive advanced breast cancer.

Integrated genomic analyses of ovarian carcinoma

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors

Identification of selective inhibitors of cancer stem cells by high-throughput screening

P304

308-314

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.MATURITAS.2013.09.008

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257837975

http://www.w3.org/2001/XMLSchema#string

P698

24128673

http://www.w3.org/2001/XMLSchema#string

P921

P932

4610026

http://www.w3.org/2001/XMLSchema#string